thiophenes has been researched along with Death, Sudden in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldi, A; Bilel, S; Botrè, F; Cerbelli, B; De-Giorgio, F; Foti, F; Marti, M; Ossato, A; Sangiorgi, E | 1 |
| Berkowitz, SD; Breithardt, G; Califf, RM; Fox, KA; Halperin, JL; Hankey, GJ; Lokhnygina, Y; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Singer, DE; Stevens, SR; Washam, JB | 1 |
| Aebischer, N; Katz, E; Pascale, P; Roguelov, C; Vogt, P; Yerly, P | 1 |
| Asai, F; Ikeda, T; Ito, T; Matsuda, K; Nakagawa, A; Oshima, T; Terada, A; Ushiyama, S; Yamazaki, M | 1 |
1 review(s) available for thiophenes and Death, Sudden
| Article | Year |
|---|---|
[Cardiology].
Topics: Cardiac Pacing, Artificial; Cardiovascular Diseases; Death, Sudden; Drug-Eluting Stents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Sports; Thiophenes | 2009 |
3 other study(ies) available for thiophenes and Death, Sudden
| Article | Year |
|---|---|
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model.
Topics: Animals; Death, Sudden; Heart Rate; Illicit Drugs; Intestines; Ischemia; Kidney; Male; Methamphetamine; Mice, Inbred ICR; Models, Animal; Myocardium; Psychotropic Drugs; Thiophenes; Vasoconstriction | 2019 |
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in
Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Death, Sudden; Diabetes Mellitus; Digoxin; Factor Xa Inhibitors; Female; Heart Failure; Heart Rate; Humans; Intracranial Embolism; Male; Morpholines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Rivaroxaban; Sex Distribution; Stroke; Thiophenes; Vitamin K; Warfarin | 2015 |
RS-5186, a novel, long-acting thromboxane synthetase inhibitor.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Death, Sudden; Dogs; Humans; In Vitro Techniques; Kinetics; Microsomes; Rabbits; Reference Values; Thiophenes; Thromboxane-A Synthase | 1989 |